首页> 外文期刊>Journal of pharmaceutical sciences. >Cyclodextrin multicomponent complexation and controlled release delivery strategies to optimize the oral bioavailability of vinpocetine.
【24h】

Cyclodextrin multicomponent complexation and controlled release delivery strategies to optimize the oral bioavailability of vinpocetine.

机译:环糊精多组分络合和控释递送策略可优化长春西汀的口服生物利用度。

获取原文
获取原文并翻译 | 示例
           

摘要

In the present work, to maintain a suitable blood level of vinpocetine (VP) for a long period of time, VP-cyclodextrin-tartaric acid multicomponent complexes were prepared and formulated in hydroxypropylmethylcellulose matrix tablets. In vitro and in vivo performances of these formulations were investigated over a VP immediate release dosage form. Solubility studies were performed to evaluate the drug pH solubilization profile and to assess the effect of multicomponent complexation on VP solubility. The drug release process was investigated using United States Pharmacopeia apparatus 3 and a comparative oral pharmacokinetic study was subsequently undertaken in rabbits. Solubility studies denoted the pH-solubility dependence of VP and solubility improvement attained by complexation. Dissolution results showed controlled and almost complete release behavior of VP over a 12-h period from complex hydroxypropylmethylcellulose-based formulations. A clear difference between the pharmacokinetic patterns of VP immediate release and VP complex-based formulations was revealed. The area under the plasma concentration-time curve after oral administration of complex-based formulations was 2.1-2.9 times higher than that for VP immediate release formulation. Furthermore, significant differences found for mean residence time, elimination half-life, and elimination rate constant values corroborated prolonged release of VP from complex-based formulations. These results suggest that the oral bioavailability of VP was significantly improved by both multicomponent complexation and controlled release delivery strategies.
机译:在目前的工作中,为了长时间保持合适的长春西汀(VP)血药水平,制备了VP-环糊精-酒石酸多组分复合物,并制成羟丙基甲基纤维素基质片剂。在VP速释剂型上研究了这些制剂的体外和体内性能。进行了溶解度研究,以评估药物的pH增溶曲线,并评估多组分络合对VP溶解度的影响。使用美国药典装置3对药物释放过程进行了研究,随后在兔子中进行了对比口服药代动力学研究。溶解度研究表明VP的pH溶解度依赖性和通过络合获得的溶解度提高。溶出度结果显示,基于复杂的羟丙基甲基纤维素的配方在12小时内可控的VP释放行为几乎完全释放。揭示了VP速释和基于VP复合物的制剂的药代动力学模式之间的明显差异。口服复合物制剂后血浆浓度-时间曲线下的面积比VP速释制剂高2.1-2.9倍。此外,发现平均停留时间,消除半衰期和消除速率常数值存在显着差异,从而证实了VP从基于复合物的制剂中延长释放。这些结果表明,多组分络合和控释递送策略均显着提高了VP的口服生物利用度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号